Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

Off-label use of rituximab for systemic lupus erythematosus in Europe.

Rydén-Aulin M, Boumpas D, Bultink I, Callejas Rubio JL, Caminal-Montero L, Castro A, Colodro Ruiz A, Doria A, Dörner T, Gonzalez-Echavarri C, Gremese E, Houssiau FA, Huizinga T, Inanç M, Isenberg D, Iuliano A, Jacobsen S, Jimenéz-Alonso J, Kovács L, Mariette X, Mosca M, Nived O, Oristrell J, Ramos-Casals M, Rascón J, Ruiz-Irastorza G, Sáez-Comet L, Salvador Cervelló G, Sebastiani GD, Squatrito D, Szücs G, Voskuyl A, van Vollenhoven R.

Lupus Sci Med. 2016 Sep 6;3(1):e000163. doi: 10.1136/lupus-2016-000163.

2.

A pathogenic IFNα, BLyS and IL-17 axis in Systemic Lupus Erythematosus patients.

López P, Rodríguez-Carrio J, Caminal-Montero L, Mozo L, Suárez A.

Sci Rep. 2016 Feb 5;6:20651. doi: 10.1038/srep20651.

3.

[Limbic encephalitis: a poorly known disease].

Martínez Zapico A, Martínez Rodríguez L, Morís de la Tassa G, Caminal Montero L.

Med Clin (Barc). 2016 May 20;146(10):465-6. doi: 10.1016/j.medcli.2015.11.027. Spanish. No abstract available.

PMID:
26749345
4.

Sarcoidosis-lymphoma syndrome.

Brandy-García AM, Caminal-Montero L, Fernández-García MS, Saiz Ayala A, Cabezas-Rodríguez I, Morante-Bolado I.

Reumatol Clin. 2016 Nov - Dec;12(6):339-341. doi: 10.1016/j.reuma.2015.11.010. English, Spanish.

5.

Registry of the Spanish Network for Systemic Sclerosis: Survival, Prognostic Factors, and Causes of Death.

Simeón-Aznar CP, Fonollosa-Plá V, Tolosa-Vilella C, Espinosa-Garriga G, Campillo-Grau M, Ramos-Casals M, García-Hernández FJ, Castillo-Palma MJ, Sánchez-Román J, Callejas-Rubio JL, Ortego-Centeno N, Egurbide-Arberas MV, Trapiellla-Martínez L, Caminal-Montero L, Sáez-Comet L, Velilla-Marco J, Camps-García MT, de Ramón-Garrido E, Esteban-Marcos EM, Pallarés-Ferreres L, Navarrete-Navarrete N, Vargas-Hitos JA, Gómez de la Torre R, Salvador-Cervello G, Rios-Blanco JJ, Vilardell-Tarrés M; Spanish Scleroderma Study Group (SSSG).; Autoimmune Diseases Study Group (GEAS).; Spanish Society of Internal Medicine (SEMI)..

Medicine (Baltimore). 2015 Oct;94(43):e1728. doi: 10.1097/MD.0000000000001728.

6.

Senescent profile of angiogenic T cells from systemic lupus erythematosus patients.

López P, Rodríguez-Carrio J, Martínez-Zapico A, Caminal-Montero L, Suarez A.

J Leukoc Biol. 2016 Mar;99(3):405-12. doi: 10.1189/jlb.5HI0215-042R.

PMID:
26232454
7.

Myocarditis and Adult onset Still disease.

Martínez Zapico A, Caminal Montero L, Costas Sueiras C, Álvarez Pichel I.

Rev Clin Esp. 2015 May;215(4):244-5. doi: 10.1016/j.rce.2014.12.008. English, Spanish. No abstract available.

PMID:
25640255
8.

Anti-ribosomal P antibodies are associated with elevated circulating IFNα and IL-10 levels in systemic lupus erythematosus patients.

Mozo L, López P, Caminal-Montero L, Rodríguez-Carrio J, Suárez A.

Lupus. 2014 Dec;23(14):1477-85. doi: 10.1177/0961203314546020.

PMID:
25107939
9.

Interferon-α-induced B-lymphocyte stimulator expression and mobilization in healthy and systemic lupus erthymatosus monocytes.

López P, Scheel-Toellner D, Rodríguez-Carrio J, Caminal-Montero L, Gordon C, Suárez A.

Rheumatology (Oxford). 2014 Dec;53(12):2249-58. doi: 10.1093/rheumatology/keu249.

10.

Influence of the IL17A locus in giant cell arteritis susceptibility.

Márquez A, Hernández-Rodríguez J, Cid MC, Solans R, Castañeda S, Fernández-Contreras ME, Ramentol M, Morado IC, Narváez J, Gómez-Vaquero C, Martínez-Taboada VM, Ortego-Centeno N, Sopeña B, Monfort J, García-Villanueva MJ, Caminal-Montero L, de Miguel E, Blanco R; Spanish GCA Consortium., Palm O, Molberg O, Latus J, Braun N, Moosig F, Witte T, Beretta L, Santaniello A, Pazzola G, Boiardi L, Salvarani C, González-Gay MA, Martín J.

Ann Rheum Dis. 2014 Sep;73(9):1742-5. doi: 10.1136/annrheumdis-2014-205261.

PMID:
24919468
11.

Common and specific associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies in systemic lupus erythematosus.

Menéndez A, Gómez J, Caminal-Montero L, Díaz-López JB, Cabezas-Rodríguez I, Mozo L.

ScientificWorldJournal. 2013 Oct 30;2013:832789. doi: 10.1155/2013/832789.

12.

Clinical associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies: Diagnostic utility of their separate detection.

Menéndez A, Gómez J, Escanlar E, Caminal-Montero L, Mozo L.

Autoimmunity. 2013 Feb;46(1):32-9. doi: 10.3109/08916934.2012.732131.

PMID:
23039326
13.

[Treatment of Wernicke encephalopathy].

Fidalgo-Navarro A, Vega-Villar J, Caminal-Montero L.

Rev Clin Esp. 2012 Jul;212(7):372-3; author reply 373. doi: 10.1016/j.rce.2012.03.001. Spanish. No abstract available.

PMID:
22525455
14.

Psoriasiform eruption triggered by a dipeptidyl peptidase IV inhibitor.

Mas-Vidal A, Santos-Juanes J, Esteve-Martinez A, Caminal-Montero L, Coto-Segura P.

Australas J Dermatol. 2012 Feb;53(1):70-2. doi: 10.1111/j.1440-0960.2011.00783.x.

PMID:
22309337
15.

Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label.

Díaz-Lagares C, Pérez-Alvarez R, García-Hernández FJ, Ayala-Gutiérrez MM, Callejas JL, Martínez-Berriotxoa A, Rascón J, Caminal-Montero L, Selva-O'Callaghan A, Oristrell J, Hidalgo C, Gómez-de-la-Torre R, Sáez L, Canora-Lebrato J, Camps MT, Ortego-Centeno N, Castillo-Palma MJ, Ramos-Casals M; BIOGEAS Study Group..

Arthritis Res Ther. 2011 Jul 11;13(4):R112. doi: 10.1186/ar3397.

16.

Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases.

Ramos-Casals M, García-Hernández FJ, de Ramón E, Callejas JL, Martínez-Berriotxoa A, Pallarés L, Caminal-Montero L, Selva-O'Callaghan A, Oristrell J, Hidalgo C, Pérez-Alvarez R, Micó ML, Medrano F, Gómez de la Torre R, Díaz-Lagares C, Camps M, Ortego N, Sánchez-Román J; BIOGEAS Study Group..

Clin Exp Rheumatol. 2010 Jul-Aug;28(4):468-76.

PMID:
20525449
17.

A case of polymyositis associated with the presence of anti-proliferating cell nuclear antigen antibodies, a marker typically considered SLE specific.

Mozo L, Caminal-Montero L, Alvarez-Almarza S, Gutiérrez C.

Lupus. 2010 Jul;19(8):1002-3. doi: 10.1177/0961203310362535. No abstract available.

PMID:
20156927
18.

[Relapsing uveitis and celiac disease].

Trapiella Martínez L, Caminal Montero L, Suárez Casado H, Fonollá Gil M.

Med Clin (Barc). 2010 Jul 10;135(5):238; author reply 239. doi: 10.1016/j.medcli.2009.05.040. Spanish. No abstract available.

PMID:
19896146
19.

[Mouth and esophageal ulcers in an HIV-infected patient].

Santos-Juanes J, Trapiella-Martínez L, Caminal-Montero L.

Actas Dermosifiliogr. 2008 Oct;99(8):653-4. Spanish. No abstract available.

PMID:
19080898
20.

[Systemic lupus erythematosus or eclampsia].

Suárez-Casado H, Cabezas-Rodríguez I, Caminal-Montero L, Díaz-López JB.

Med Clin (Barc). 2008 Sep 6;131(7):276. Spanish. No abstract available.

PMID:
18775221
Items per page

Supplemental Content

Loading ...
Support Center